# FDA Inspection 661469 - Bridgewest Perth Pharma Pty Ltd. - April 15, 2010

Source: https://www.keypedia.com/records/fda_inspections/bridgewest-perth-pharma-pty-ltd/58e1aeef-5d83-4616-9b42-de9e2caecf3f
Source feed: FDA_Inspections

> FDA Inspection 661469 for Bridgewest Perth Pharma Pty Ltd. on April 15, 2010. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 661469
- Company Name: Bridgewest Perth Pharma Pty Ltd.
- Inspection Date: 2010-04-15
- Classification: No Action Indicated (NAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1181103 - 2022-08-23](https://www.keypedia.com/records/fda_inspections/bridgewest-perth-pharma-pty-ltd/bcf63235-5f34-40e9-9cce-3a1850d740b7)
- [FDA Inspection 913452 - 2015-01-30](https://www.keypedia.com/records/fda_inspections/bridgewest-perth-pharma-pty-ltd/7b17573e-6d5c-4041-823e-dc4aeb1e3c9b)
- [FDA Inspection 812432 - 2012-12-13](https://www.keypedia.com/records/fda_inspections/bridgewest-perth-pharma-pty-ltd/37fbacfb-5360-4fb3-9c6d-79c861f6e247)

Company: https://www.keypedia.com/companies/bridgewest-perth-pharma-pty-ltd/9cbc4ae0-049d-4911-95d5-bb44a477346e

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c